Back
Intellia Therapeutics Vs. Equifax Industry Stock Comparison
Sell
35
NTLA
Intellia Therapeutics
Last Price:
23.28
Seasonality Move:
31.89%
Buy
58
EFX
Equifax
Last Price:
224.64
Seasonality Move:
3.45%
Sell
35
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
- The current Intellia Therapeutics [NTLA] share price is $22.50. The Score for NTLA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- NTLA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Equifax (EFX)
is a Buy
Is Equifax a Buy, Sell or Hold?
- The current Equifax [EFX] share price is $220.67. The Score for EFX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- EFX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $22.50
The current trend is relatively stagnant and NTLA is experiencing slight buying pressure.
EFX Stock Price Chart
NTLA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.36 | Sell |
Relative Strength Index (14 RSI): | 44.72 | Sell |
Chaikin Money Flow: | 82529 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.3 - 25.7) | Sell |
Bollinger Bands (100): | (24.07 - 30.23) | Sell |
EFX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -9.5 | Sell |
Relative Strength Index (14 RSI): | 32.85 | Sell |
Chaikin Money Flow: | -394075 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (223.76 - 257.44) | Sell |
Bollinger Bands (100): | (235.19 - 262.33) | Sell |
NTLA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.4 | Buy |
20-day SMA: | 22.79 | Sell |
50-day SMA: | 26.18 | Sell |
200-day SMA: | 30.28 | Sell |
8-day EMA: | 21.72 | Buy |
20-day EMA: | 22.79 | Sell |
50-day EMA: | 24.91 | Sell |
200-day EMA: | 30.37 | Sell |
EFX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 223.15 | Sell |
20-day SMA: | 235.64 | Sell |
50-day SMA: | 252.36 | Sell |
200-day SMA: | 221.7 | Sell |
8-day EMA: | 224.26 | Sell |
20-day EMA: | 233.33 | Sell |
50-day EMA: | 243.24 | Sell |
200-day EMA: | 230.59 | Sell |
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $0.02 per share.
Equifax Earnings Growth & EFX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.25 per share, an increase this year of $0.73 per share, and an increase next year of $2.17 per share.
Intellia Therapeutics Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Equifax Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |